Remarkably, the association between Hippo pathway inactivation and liver fibrosis was also noted by Wang et al. [112], who analyzed TAZ expression in human livers affected by NASH-related fibrosis and in various mouse NASH models. This evidence concerns the gene WWTR1 and metabolic dysfunction-associated steatohepatitis.